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Do evidence practice gaps exist for medication
prescription at hospital discharge in patients
undergoing coronary artery bypass and coronary
angioplasty
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Background: Adherence to guideline directed medical therapy
(GDMT) althoughmandatory after CABG& percutaneous coronary
intervention (PCI), is often sub-optimal at hospital discharge.
Since relevant data are lacking from our country, we performed a
retrospective analysis of medication advice following CABG and
PCI from 2010-2013.
Methods: A total of 5258 records (PCI/CABG:86.2vs13.8%) were
studied.
Results: Presentation with stable angina was commoner in CABG
group (61.4 vs 39.4%, p<0.001) while ACS was more in PCI group
(61.6 vs 38.9% p<0.001). Prescription rates for dual anti-platelets
(aspirin 100% vs 99%, clopidogrel 100% vs 96.9%), beta blockers
(98.4% vs 93.7%) and statins (99.1% vs 90.9%) were similar in PCI &
CABG groups. ACE inhibitors (94.2% vs 47.2%) & nitrates (58.2% vs
0.8%, both p < 0.001) were prescribed more often post-PCI. Despite
similar LVEF (46.8% vs 48.2%), diuretics were prescribed univer-
sally post- CABG (99.1% vs 14.8%, p<0.001). Calcium channel
blockers were prescribed in < 5% & more often post PCI (4.9 vs
2.2%, p<0.001).
Drug doses: For Aspirin, 150 mg OD was the commonest dose
used (94.6% vs 88.2%; PCI/CABG). Clopidogrel 75 mg BD was used
more often post PCI (82.5% vs 1.7%) while 75 mg od more post
CABG (6.4% vs 95.2%). Statin 40-80 mg was prescribed more often
post PCI (68.2% vs 0.3% and 9.8% vs 0% respectively, p0.001). Statin
10 mg was used in 82.5% post CABG vs 5.4% post PCI (p 0.001). A 50
mg dose of betablocker was used in 74.2% post PCI vs 42.1% post
CABG; 25 mg betablokcer was prescribed in 47% and 21.1% of post
CABG & post PCI patients (all p< 0.01).
Conclusions: Significant differences in prescription of GDMT exist
at hospital discharge even in a tertiary centre. Post CABG, 7% and
53% patients were not prescribed a betablokcer & ACEI respec-
tively. Post CABG, patients were less likely to receive high dose
statinor optimal betablokcer dose&more likely to receivediuretics
(irrespective of EF). Post-PCI, 80 mg statin was used in < 10%. Such
evidence practice gaps need to be rectified to improve cardiac care.
Pudendal artery angioplasty for the treatment of
complex erectile dysfunction in males
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Background: Erectile Dysfunction (ED) is an important and
growing health problem. It is estimated that more than 200
millionmen (between the age of 40e 70 years) suffer from ED. The
real prevalence could be much higher as it is underreported and
undertreated. Out of the many etiologies, 80% of cases are of
vasculogenic origin. Venous leak and arterial inflow problems
(usually pudendal artery stenosis) are the most common
etiologies. In patients who fail PDEe5 inhibitors therapy (Complex
ED), vasculogenic causes should be strongly suspected.
Methods: The workup is done by excluding the endocrinal, uro-
logical and psychological causes and then subjecting these pa-
tients to a penile Doppler study (after intra cavernosal injection of
papaverine). In patients where the peak systolic penile velocity is
less than 25cm/sec, pudendal artery stenosis is strongly sus-
pected. These patients then undergo a selective angiography for
identification of pudendal artery stenosis. If the stenosis is found,
they are subjected to super selective pudendal artery cannulation
and angioplasty or stenting using drug eluting balloon (DEB) or
zotarolimus eluting stents (DES). Patients are followed up at 3, 9,
12 months and then after every year by Duplex scans.
Results: 36 consecutive worked up patients of complex ED with
pudendal artery stenosis underwent pudendal artery angioplasty
(with DEB or DES). The procedure was successful in all patients.
There was no death, perineal or penile gangrene. Themean penile
velocity increased from base line of 16cm/sec to 44, 50, 58cm/sec
at 3, 6, 12 months respectively. Improvement > 4 points in Inter-
national Index of Erectile Functions (IIEF -6) score at 3, 6 and 12
months were 68 %, 75 % and 78 % respectively.
Conclusions: Angioplasty of focal stenosis of internal pudendal
artery by DEB or DES appears to be a very promising therapy for
male erectile dysfunction. It is safe, feasible and leads to sustained
improvement of male erectile dysfunction.
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Background: Central venous occlusions (CVOs) are a common
complication that may arise after the placement of central venous
catheters, especially in patients of chronic renal failure undergo-
ing maintenance hemodialysis and patients with indwelling
pacemaker leads. Patients may present with Superior Vena Cava
(SVC) syndrome (symptoms of upper limb and cranial venous
hypertension leading to swelling of face and upper limbs) and
inability to continuewith hemodialysis. Till recently, there was no
satisfactory and durable treatment for these patients, but of late,
endovascular recanalization of CVOs has become feasible and a
successful treatment option in these patients. Surgery carries a
very high morbidity as is often unsuccessful.
Methods: Patients presented with SVC syndrome. Diagnosis of
CVO was made by angiography. Anatomical details like site and
length of occlusion, collateral pathways, presence or absence of
thrombus and distal venous anatomy were noted. The CVOs were
recanalised through either femoral, brachial or subclavian
approach using 0.035” hydrophilic guide wires, extra backup
telescopic catheters, non compliant peripheral balloons (Mustang,
Boston Scientific) and self expanding stent implantation (Epic,
Boston Scientific). Patients were kept on dual antiplatelet for one
month followed by Aspirin 150mg daily. Hemodialysis was initi-
ated immediately after the procedure.
Results: N ¼ 97; Subclavian Vein - 35; Brachiocepahlic Vein 13;
Superior Vena Cava 23 and Combined Lesions - 26 Technical
Success in 91 /97; Percutaneous Transluminal Angioplasty (PTA)
in 69; Stents-22 and Catheter Directed Thrombolytic Therapy
(CDTT) 23 Patency: Primary (at 6 months) : 48%, Secondary (at 1
year) : 87%.
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Conclusions: SVC syndrome because of CVO is now amenable to
interventional treatment. These patients go back to normalcy and
maintenance hemodialysis immediately after the procedure. This
is the largest reported series in India of SVC syndrome/CVO
treated by Endovascular approach.
Endovenous Laser therapy by Laser blast
technique for treating varicose vein e Experience
of the largest series of 6,018 patients
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Background: Venous reflux is seen in about 8% of adult popula-
tion. Till now surgery was considered to be the gold standard.
Recently, Endo-Venous Laser Therapy (EVLT) has been used with
great success with a recurrence rate of less than 7% after two
years. This abstract discusses our results of 6018 successive cases
of varicose veins treated by novel laser blast technique.
Methods: 6018 patients of severe sapheno-femoral incompetence
were treated by EVLT using 25 watts Diode laser machine. Venous
access was gained near the ankle using duplex scanning. A 5F
sheath was inserted into the great saphenous vein and advanced
upto 2 inches below the saphenofemoral junction. 810 mmbare tip
laser fibres were used and was advanced through the sheath. The
position of the fibre tip was confirmed by the red light (at the tip)
which is seen through the skin. The sheath and the fibre were
then withdrawn while delivering the laser energy at a rate of
about 1 mm/sec delivering about 12joules/pulse/sec. Individual
perforators, short saphenous vein and extra-axial varicosities
were treated and the completeness of the procedure was assessed
by angiographic guidance. Patients were followed-up by duplex
scan after one day, one month, six months and one year.
Results: N ¼ 6018; Great Saphenous Vein (GSV) 3948, Short Saphe-
nous Vein (SSV) 1520 and Both (GSV + SSV) 1428, Perforators 783.
Adjuvant Sclerotherapy / Perforator Ligation / ablation 140;
Wavelength of LASER 810mm and System BIOLITIC.
Avg. lasering time 3 -5 mins, and avg. procedure time 62 mins
Procedural Success 6018/6018, Immediate Mobilisation 6018/
6018
Complications included: DVT 17/6018, Pain 1268/6018, Swelling
78/6018, Ecchymosis 906/6018 and Pulmonary Embolism 0/6018.
Follow Up: Freedom from recurrence at 6mnths - 97%; 12mnths
- 94%.
Conclusion: EVLT is an outdoor, quick, successful minimally
invasive procedure to treat venous varicosities due to sapheno-
femoral reflux. The patients'compliance is excellent, with very
low recurrence rate of about 6%.
Prognostic value of plasma N-terminal pro-Brain
natrituretic peptide and high sensitivity troponin
T in patients with sepsis; correlation with C
reactive protein level and 2D echocardiography
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Background: Increased levels of pro-BNP and Hs trop T as a pre-
dictors of cardiac dysfunction and prognosis in congestive heart
failure and ischemic heart disease have been identified. But only a
few studies identifytheir role in septicmyocardial injury. Base line
parameters and the level of Hs Troponin T in distinguishing septic
myocarditis from acute coronary events are also not well studied.
Aim: To determine the role of the pro-BNP and hS troponin T in
the context of outcome of septic patients; to analyze their corre-
lation with c reactive protein level and 2d echocardiogragraphy
findings. Base line parameters and level of hS troponin in helping
to distinguish septicmyocarditis from acute coronary events were
also evaluated.
Methods and Results: 1OO consecutivepatients with sepsis were
included. Levels of pro-BNP, Hs troponin T, C reactive proteinwere
measured on the day of diagnosis of sepsis. 2d echocardiography
was performed on the same day and repeated on the day of
discharge. Patients had myocardial injury diagnosed by elevated
Hs Troponin T, and elevated pro-BNP. Patients with Pro-BNP level
>4000 pmol/L had increased morbidity and the level >25000 pre-
dicted 90% mortality. Level of hS troponin T showed a linear
correlation with pro- BNP levels, but pro BNP was more sensitive
in prognostication. Level of Hs Troponin T >500 was indicative of
an acute coronary event rather than septic myocarditis. This
correlatedwith ECG and echo findings and later with coronary
angiogram in selective patients.
Conclusion: Pro-BNP and Hs troponin T may serve as useful lab-
oratory marker to predict survival in patients with sepsis. Serial
evaluation of Hs troponin T may also help to distinguish septic
myocardial injury from acute coronary events.
Interventional approach for management of acute
deep vein thrombosis (DVT)
N.N. Khanna, Suparna Rao, Obiora Ajuluchukwu
Indraprastha Apollo Hospital, New Delhi, India
Background: Although DVT of calf veins is most common, 40% of
DVTs occur in the femoral and iliac veins and have a high risk of
pulmonary thromboembolism and Post Thrombotic Syndrome
(PTS), which can be avoided by timely interventional manage-
ment. Catheter Directed Thrombolytic Therapy (CDTT) and
Pharmacomechanical Catheter-Directed Thrombolysis (PCDT),
(combination of CDTT with percutaneous mechanical thrombec-
tomy) is the best possible solution. This dual mechanism of action
enhances the efficiency and rate of thrombus removal. It also
uncovers the May Thurner syndrome in many cases.
Methods: Diagnosis was made by Duplex scan and venography.
Patients with DVT extending to common femoral vein and above
were included. Popliteal vein was accessed under Duplex guid-
ance and a 6F sheath was introduced. Suction thrombectomy was
done using 6Fmultipurpose guiding catheter and amulti side hole
infusion catheter was used to deliver continuous intra-clot tissue
infusion of tPA for 24-48 hrs. More than 50% angiographic clear-
ance of the thrombus was used as criteria of success and if May
Thurner syndrome was uncovered, left common iliac vein was
stented by self-expanding stents. Patients were then kept on oral
anticoagulants, to maintain an INR of 2.5-3.5.
Results: N ¼ 26; Duration of DVT:  14 days.
Involvement: Femoral Vein ¼ 26 ; External Iliac Vein ¼ 20 ;
Common Iliac Vein ¼ 13 ; IVC ¼ 3
Procedure: Thrombolytic agent tPA.
Aspiration Thrombectomy (AT) ¼ 26/26 ; CDTT ¼ 26/26.
Reduction of Thrombus load:
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